These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 8523655

  • 1. [The mu, delta and kappa properties of various opioids].
    Ohta S, Niwa M, Nozaki M, Hattori M, Shimonaka H, Dohi S.
    Masui; 1995 Sep; 44(9):1228-32. PubMed ID: 8523655
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA, Traynor JR.
    Brain Res; 2006 Feb 16; 1073-1074():290-6. PubMed ID: 16443205
    [Abstract] [Full Text] [Related]

  • 3. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
    Emmerson PJ, Liu MR, Woods JH, Medzihradsky F.
    J Pharmacol Exp Ther; 1994 Dec 16; 271(3):1630-7. PubMed ID: 7996478
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK, Meert TF.
    J Pharmacol Exp Ther; 2002 Sep 16; 302(3):1253-64. PubMed ID: 12183687
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells.
    Standifer KM, Cheng J, Brooks AI, Honrado CP, Su W, Visconti LM, Biedler JL, Pasternak GW.
    J Pharmacol Exp Ther; 1994 Sep 16; 270(3):1246-55. PubMed ID: 7932177
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and SAR study of opioid receptor ligands: mono- and bis-indolomorphinans.
    Li F, Yin C, Chen J, Liu J, Xie X, Zhang A.
    Chem Biol Drug Des; 2009 Oct 16; 74(4):335-42. PubMed ID: 19691470
    [Abstract] [Full Text] [Related]

  • 10. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.
    Townsend D, Portoghese PS, Brown DR.
    J Pharmacol Exp Ther; 2004 Jan 16; 308(1):385-93. PubMed ID: 14569065
    [Abstract] [Full Text] [Related]

  • 11. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ, Benyas S, Horwitz JA, Thompson K, Mathewson C, Smith MA.
    J Pharmacol Exp Ther; 1996 Dec 16; 279(3):1130-41. PubMed ID: 8968334
    [Abstract] [Full Text] [Related]

  • 12. Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists.
    Cohen ML, Mendelsohn LG, Mitch CH, Zimmerman DM.
    Receptor; 1994 Dec 16; 4(1):43-53. PubMed ID: 8038706
    [Abstract] [Full Text] [Related]

  • 13. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH, Sumpter TL, Burke TF, Husbands SM, Lewis JW, Woods JH, Traynor JR.
    J Pharmacol Exp Ther; 2000 Sep 16; 294(3):933-40. PubMed ID: 10945843
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
    Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, Reisine T.
    Mol Pharmacol; 1994 Feb 16; 45(2):330-4. PubMed ID: 8114680
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
    Neilan CL, Husbands SM, Breeden S, Ko MC, Aceto MD, Lewis JW, Woods JH, Traynor JR.
    Eur J Pharmacol; 2004 Sep 19; 499(1-2):107-16. PubMed ID: 15363957
    [Abstract] [Full Text] [Related]

  • 16. Roles of different subtypes of opioid receptors in mediating the ventrolateral orbital cortex opioid-induced inhibition of mirror-neuropathic pain in the rat.
    Zhao M, Wang JY, Jia H, Tang JS.
    Neuroscience; 2007 Feb 23; 144(4):1486-94. PubMed ID: 17184926
    [Abstract] [Full Text] [Related]

  • 17. The stimulatory effect of mu- and delta-opioid receptors on bovine pinealocyte melatonin synthesis.
    Chuchuen U, Ebadi M, Govitrapong P.
    J Pineal Res; 2004 Nov 23; 37(4):223-9. PubMed ID: 15485547
    [Abstract] [Full Text] [Related]

  • 18. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM, Li QL, Zhang CF, Xu XJ, Chen J, Ju YW, Chi ZQ, Long YQ, Liu JG.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):306-11. PubMed ID: 18353307
    [Abstract] [Full Text] [Related]

  • 19. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
    Bradford CS, Walthers EA, Stanley DJ, Baugh MM, Moore FL.
    Gen Comp Endocrinol; 2006 May 01; 146(3):275-90. PubMed ID: 16375901
    [Abstract] [Full Text] [Related]

  • 20. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.
    Watson B, Meng F, Akil H.
    Neurobiol Dis; 1996 Feb 01; 3(1):87-96. PubMed ID: 9173916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.